- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03616613
Aortic Abdominal Aneurysm Pilot Screening Programme
August 3, 2018 updated by: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Analysis of Aortic Abdominal Aneurysm Prevalence in a Population Pilot Screening Program Based on Primary Care Duplex Ultrasound Evaluation
Populational abdominal aortic aneurysm (AAA) pilot screening programme performed by duplex ultrasonography in population born in 1952 in health areas depending from Hospital de la Santa Creu i Sant Pau in Barcelona.
Descriptive data analysis and cost-effectiveness study will be performed.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Populational abdominal aortic aneurysm (AAA) pilot screening programme performed by duplex ultrasonography in population born in 1952 in areas depending from Hospital de la Santa Creu i Sant Pau in Barcelona.
Ultrasonography evaluations will be performed in primary health centers by previously trained doctors according to study protocol and AAA management will be according to United Kingdom's National Health Service screening model.
A descriptive analysis will be performed to estimate local population prevalence of AAA in both men and women in order to create the basis for a future state AAA screening programme.
A cost-effectiveness analysis will be performed in order to assess optimal screening strategies in our population.
Study Type
Observational
Enrollment (Actual)
2194
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
65 years to 65 years (Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
All men and a random sample of women born in 1952 in Barcelona in the area that depends from Hospital de la Santa Creu i Sant Pau.
Description
Inclusion Criteria:
- All men in our area's population census and an aleatory sample of women born in 1952 living in Hospital de la Santa Creu i Sant Pau area.
Exclusion Criteria:
- Previously detected or operated AAA
- Fragile patients not eligible for AAA repair if needed
- Dead people when contacted
- Eligible people refusing to participate
- Eligible people failed to be contacted twice by our department
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Men
Men born in 1952 in Barcelona in health areas depending from Hospital de la Santa Creu i Sant Pau.
|
Abdominal ultrasonography performed by both primary care doctors or vascular surgeons in Hospital de la Santa Creu i Sant Pau area
|
Women
Aleatory sample of women born in 1952 in Barcelona in health areas depending from Hospital de la Santa Creu i Sant Pau.
|
Abdominal ultrasonography performed by both primary care doctors or vascular surgeons in Hospital de la Santa Creu i Sant Pau area
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Abdominal aortic measurement
Time Frame: Days (only one day measurement is performed)
|
Ultrasound infrarrenal aortic diameter measurement in mm
|
Days (only one day measurement is performed)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Smoking habits
Time Frame: 1 day
|
Defined by current smoker, former smoker (more than one year without smoking) or non smoker
|
1 day
|
Surgical intervention if needed
Time Frame: 1 day
|
Registry of kind of intervention and date of intervention
|
1 day
|
Family AAA history
Time Frame: 1 day
|
First or second degree relatives with AAA, or no family AAA history
|
1 day
|
Personal Cardiovascular Risk Factors
Time Frame: 1 day
|
Coronary disease, neurovascular disease, peripheral arterial disease or diabetes mellitus
|
1 day
|
Dislipidaemia
Time Frame: 1 day
|
Altered lipid parameters in blood analysis
|
1 day
|
Arterial Hypertension
Time Frame: 1 day
|
Arterial hypertension under medical treatment
|
1 day
|
Height
Time Frame: 1 day
|
measures in cm
|
1 day
|
Weight
Time Frame: 1 day
|
measures in kg
|
1 day
|
Abdominal perimeter
Time Frame: 1 day
|
measures in cm
|
1 day
|
Goldberg questionnaire
Time Frame: 1 day
|
Complete goldberg anxiety and depression questionnaire.
It consists of 12 questions and 5 posible answers for each question, and each answer is rated with 1 to 5 points.
Total score above 9 indicates risk of depression.
|
1 day
|
EuroQOL 5 score
Time Frame: 1 day
|
EuroQOL 5 quality of life evaluation questionnaire.
It consistis of 5 questions with 3 posible answers for each question, and a visual analogical scale for self health perception.
Each combination of answers indicates a pattern of health status that can be rated.
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2017
Primary Completion (Actual)
December 31, 2017
Study Completion (Actual)
June 1, 2018
Study Registration Dates
First Submitted
June 14, 2018
First Submitted That Met QC Criteria
August 3, 2018
First Posted (Actual)
August 6, 2018
Study Record Updates
Last Update Posted (Actual)
August 6, 2018
Last Update Submitted That Met QC Criteria
August 3, 2018
Last Verified
August 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IIBSP-AAA-2017-42
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aortic Aneurysm, Abdominal
-
EndologixActive, not recruiting1 Paravisceral Abdominal Aortic Aneurysm | 2 Juxtarenal Abdominal Aortic Aneurysm | 3 Pararenal Abdominal Aortic Aneurysm | 4 Complex Abdominal Aortic AneurysmsUnited States
-
Assistance Publique - Hôpitaux de ParisUnknownSmall Abdominal Aortic Aneurysm | Abdominal Aortic Aneurysm,France
-
Karolinska University HospitalEnrolling by invitationAneurysm | Aortic Aneurysm | Abdominal Aortic Aneurysm, Ruptured | Aneurysm Abdominal | Abdominal Aortic Aneurysm Without RuptureSweden
-
Medtronic CardiovascularCompletedAbdominal Aortic Aneurysms (AAA)United States
-
Vascutek Ltd.TerminatedAbdominal Aortic Aneurysms (AAA)United Kingdom, Netherlands, Switzerland, Spain, Germany, Belgium, Sweden, Canada, France, Italy, Austria, Monaco
-
Washington University School of MedicineRecruitingAbdominal Aortic Aneurysm (AAA) | No Abdominal Aortic Aneurysm (Non-AAA)United States
-
University of California, San DiegoRecruitingJuxtarenal Aortic Aneurysm | Thoracoabdominal Aortic Aneurysm | Pararenal Aortic Aneurysm | Complex Abdominal Aortic AneurysmUnited States
-
Timothy Chuter, MDRecruitingThoracoabdominal Aortic Aneurysm | Paravisceral Abdominal Aortic AneurysmUnited States
-
Assistance Publique Hopitaux De MarseilleCompletedAbdominal Aortic AneurysmsFrance
-
Hangzhou Endonom Medtech Co., Ltd.RecruitingJuxtarenal Abdominal Aortic AneurysmChina
Clinical Trials on ABDOMINAL DUPLEX ULTRASONOGRAPHY
-
Seoul National University HospitalCompletedEnd Stage Renal DiseaseKorea, Republic of
-
Yonsei UniversityCompletedEnd Stage Renal DiseaseKorea, Republic of
-
Hospices Civils de LyonCompletedCarotid AtherosclerosisFrance
-
Basaksehir Cam & Sakura Şehir HospitalRecruitingCoronary Artery Disease | Abdominal Aortic AneurysmTurkey
-
University Hospital Inselspital, BerneTerminatedCardiopulmonary BypassSwitzerland
-
Hospital de GranollersCompleted
-
Masaryk Hospital Krajská zdravotní a.s.Unknown
-
Nantes University HospitalCompletedVenous ThrombosisFrance
-
Clalit Health ServicesMedtronicCompleted
-
National and Kapodistrian University of AthensCompletedFabry DiseaseGreece